Lemaitre Vascular (LMAT) Equity Ratio (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Equity Ratio data on file, last reported at 0.65 in Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.65, up 3.33% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.65 (up 3.33% YoY), and the FY2025 annual result was 0.64, up 4.57% from the prior year.
• Equity Ratio grew to 0.65 in Q1 2026 per LMAT's latest filing, from 0.64 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.88 in Q1 2022 and troughed at 0.61 in Q4 2024.
• A 5-year average of 0.79 and a median of 0.86 in 2022 frame the typical range for Equity Ratio.
• The sharpest annual moves came in 2022 and 2024: Equity Ratio climbed 22.83% in 2022, then decreased 28.85% in 2024.
• A 5-year view of Equity Ratio shows it stood at 0.86 in 2022, then retreated by 0.55% to 0.86 in 2023, then declined by 28.85% to 0.61 in 2024, then advanced by 4.57% to 0.64 in 2025, then gained by 1.06% to 0.65 in 2026.
• Business Quant data shows LMAT's Equity Ratio at 0.65 in Q1 2026, 0.64 in Q4 2025, and 0.63 in Q3 2025.